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Sleep is a physiological process involving different biological systems, from molecular to
organ level; its integrity is essential for maintaining health and homeostasis in human
beings. Although in the past sleep has been considered a state of quiet, experimental
and clinical evidences suggest a noteworthy activation of different biological systems
during sleep. A key role is played by the autonomic nervous system (ANS), whose
modulation regulates cardiovascular functions during sleep onset and different sleep
stages. Therefore, an interest on the evaluation of autonomic cardiovascular control in
health and disease is growing by means of linear and non-linear heart rate variability
(HRV) analyses. The application of classical tools for ANS analysis, such as HRV during
physiological sleep, showed that the rapid eye movement (REM) stage is characterized by
a likely sympathetic predominance associated with a vagal withdrawal, while the opposite
trend is observed during non-REM sleep. More recently, the use of non-linear tools, such
as entropy-derived indices, have provided new insight on the cardiac autonomic regulation,
revealing for instance changes in the cardiovascular complexity during REM sleep,
supporting the hypothesis of a reduced capability of the cardiovascular system to deal
with stress challenges. Interestingly, different HRV tools have been applied to characterize
autonomic cardiac control in different pathological conditions, from neurological sleep
disorders to sleep disordered breathing (SDB). In summary, linear and non-linear analysis
of HRV are reliable approaches to assess changes of autonomic cardiac modulation
during sleep both in health and diseases. The use of these tools could provide important
information of clinical and prognostic relevance.
Keywords: autonomic nervous system, heart rate variability, sleep, non-linear analysis, obstructive sleep apnea,
insomnia, SUDEP
“But what interests me here is the specific mystery of sleep par-
taken of or itself alone, the inevitable plunge risked each night by the
naked man, solitary and unarmed, into an ocean where everything
changes, the colors, the densities, and even the rhythm of breathing,
and where we meet the dead. What reassures us about sleep is that
we do come out of it, and come out of it unchanged, since some mys-
terious ban keeps us from bringing back with us in their true form
even the remnants of our dreams”
Memories of Adrian, Marguerite Yourcenar, 1951
Abbreviations: AHI, apnea/hypopnea index; ANS, autonomic nervous system;
BP, blood pressure; BRS, baroreflex sensitivity; CAP, cyclic alternating pattern;
CCE, corrected conditional entropy; CE, conditional entropy; CPAP, continu-
ous positive airway pressure; EEG, electroencephalogram; HF, high frequency;
HR, heart rate; HRV, heart rate variability; LF, low frequency; MSNA, mus-
cle sympathetic nerve activity; NCAP, non-CAP; NREM, non-REM; NU, nor-
malized units; OSA, obstructive sleep apnea; PI, primary insomnia; REM,
rapid eye movement; Ro, regularity index; SDB, sleep disordered-breathing;
SE, Shannon entropy; SUDEP, sudden unexpected death in epilepsy; SWS,
slow wave sleep; VLF, very low frequency; VLPO, ventrolateral preoptic
nucleus.
INTRODUCTION
The simple observation that human beings, mammals and other
animal species spend about one third or more of their lifetime
sleeping strongly suggest how fundamental the physiological pro-
cess of sleeping is (Chou et al., 2003; Saper et al., 2005).
Despite the fact that a large amount of data has been pub-
lished on the biological meaning and function of sleep, several
key points still need to be clarified.
The sleep process is characterized by the activation of a
number of cortical, subcortical and medullar neural circuits,
which cooperate in order to control sleep according to hormonal
changes (i.e., melatonin and orexin), local factors such as adeno-
sine accumulation, circadian variations (i.e., dark-light cycles)
and other unknown factors (Saper et al., 2005). A key role in
the physiology of sleep is played by the autonomic nervous sys-
tem (ANS), whose regulation modulates cardiovascular functions
during sleep onset and the transition to different sleep stages.
The analysis of heart rate variability (HRV) has been widely
used as a non-invasive and reliable tool to evaluate cardiovas-
cular autonomic control in health and disease. The application
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of different tools, such as linear and non-linear analysis of HRV
during different sleep stages provided fundamental insight on
the physiological autonomic changes that characterize wake-to-
sleep transition, sleep onset, and different sleep stages [rapid eye
movement (REM) and non-REM sleep (NREM)]. In addition,
different HRV tools revealed important modifications of auto-
nomic cardiac control in different pathological conditions, such
as insomnia, primary neurological sleep disorders, and sleep dis-
ordered breathing (SDB), a group of diseases associated with
an alteration in the normal breathing during sleep (Parish and
Somers, 2004; Nobili et al., 2011).
The present review will focus on the fundamental princi-
ples of sleep structure, the most used linear and non-linear
analyses of HRV and the application of these tools to assess
the autonomic cardiac control in normal and pathological
sleep.
WAKEFULNESS-SLEEP TRANSITIONS
Transition from wake to sleep is relatively rapid, considering that
sleep onset is a process which lasts no more than one minute in
human beings (Takahashi et al., 2010).
Interestingly, the switch fromwake to sleep and among the dif-
ferent sleep stages is not monodirectional (i.e., from NREM, to
REM), but, on the contrary, it oscillates from NREM to REM and
vice versa, together with fast changes in electroencephalographic
(EEG) cerebral waves and the occurrence of arousals (Saper et al.,
2010).
The neural regulation of this process is very complex, counting
several neural networks of neurons located both in the cortex and
in the medulla. A key regulatory mechanism in the wake to sleep
shift is the relation between hypothalamic and monoaminergic
neurons. In fact, it has been shown that monoaminergic neu-
rons in the pons project to noradrenergic neurons in the locus
coeruleus and to dopaminergic and serotoninergic relay stations
in the raphe (Saper et al., 2010). Wake period is characterized
by firing activity of these monoaminergic neurons, which inhibit
ventrolateral preoptic nucleus (VLPO) and neurons which reg-
ulate the transition to REM sleep; this mechanism is capable of
limiting a direct transition from wake to REM sleep. On the con-
trary, sleep is characterized by an increased activity of VLPO
neurons, which, in turn, inhibits monoaminergic neurons, and,
consequentially, triggers the sleep onset. This regulatory mecha-
nism is only one of the most important neural network involved
in the wakefulness—sleep switch, and it is called the flip-flop
switch model (Saper et al., 2010).
The full description of the neural networks regulating the shift
from NREM to REM sleep and vice versa is out of the scope of
this review.
SLEEP STRUCTURE
Sleep macrostructure is characterized by two separate physiologi-
cal stages, REM sleep and NREM sleep.
REM sleep, identified in 1953, is a physiological state that
includes REM and low muscle tone. On the opposite, NREM
sleep is usually divided into two states, light sleep (NREM 1 and
NREM2, or N1 and N2) and deep sleep (NREM3, or N3, also
called Slow Wave Sleep, SWS); during NREM sleep rapid eyes
movements are absent while muscle tone is usually considerable.
REM and NREM sleep are characterized by typical EEG features.
In fact, during wakefulness with closed eyes, on the EEG a typ-
ical rhythm, the alpha rhythm, becomes evident. Alpha rhythm
is characterized by low voltage and high frequency waves, with a
frequency band bounded between 8 and 12Hz.
During doziness and sleep onset, cortical rhythm slows, alpha
rhythm disappears and theta rhythm appears alongside the alpha;
lower frequency (3.5–7.5Hz) and higher voltage waves create
theta rhythm; alpha disappears as sleep becomes deeper.
During N2, alpha rhythm completely disappears and theta
rhythm is the dominant EEG oscillation. In addition, two pecu-
liar EEG elements become evident at this time: spindles and
K complexes. Spindles derive from bursts of brain activity and
are characterized by high frequency waveform (12–14Hz) last-
ing more than 0.5 s, while waves with a first negative-high voltage
peak followed by slow positive complex and a second negative
peak are called K complexes. Their rate of occurrence is roughly
every 1–2min.
The transition from N2 to N3 is associated with the appear-
ance of delta waves, which have high voltage (greater than 75µV)
and low frequency (bounded between 0.5 and 3Hz). N3 is the
sleep stage of highest synchronization of neural activity in the
brain, with low muscle activity and no REMs. From N3 to REM,
delta waves disappear and high frequency and low voltage waves
become predominant; complete muscle atonia and REMs are
observed.
HEART RATE VARIABILITY AS A WINDOW OVER
AUTONOMIC CARDIOVASCULAR CONTROL
The two branches of the ANS, sympathetic and parasympathetic
nervous system, regulate visceral functions in order to maintain
the homeostatic milieu of the body and to render the body able
to react and to adapt to external and internal stressor stimuli
(Malliani et al., 1991; Montano et al., 2009) (see Figure 1).
A very composite and interconnected regulating mechanisms
operate at different levels, both central and peripheral, in order to
coordinate ANS functions (Montano et al., 2009).
FIGURE 1 | A schematic representation of autonomic nervous system
functions and its integration with internal and external stressor
stimuli (from Montano et al., 2009; with permission).
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Within physiological conditions, the regulation of several fun-
damental visceral functions, such as cardiovascular, respiratory,
and gastrointestinal systems, is based on the reciprocal activation
of the two autonomic subsystems, the so-called “sympatho-vagal
balance”: the activation of one branch, i.e., sympathetic outflow,
is associated with a withdrawal of the other, i.e., parasympathetic
drive, and vice versa (Malliani et al., 1998). This mechanism has
been considered a key stone paradigm of the ANS function for
many years; however, it has been suggested that the coactiva-
tion of both sympathetic and parasympathetic systems is not only
physiologically possible, but it is also a rule in peculiar situations
such as chemoreceptor reflexes (i.e., during apneas), exercise, and
cold face immersion (Koizumi et al., 1982;Malliani andMontano,
2002; Paton et al., 2005).
These brief observations suggest the high degree of complexity
of the ANS regulation, mainly due to the strong interconnection
with several biological systems (central and peripheral nervous
systems, immunity, inflammation, metabolism, hormones etc.)
and to its multifaceted mechanisms of action of sympathetic and
parasympathetic limbs (i.e., as antagonists or agonists).
For many years, several techniques have been developed for
the assessment of ANS: (a) dosage of plasmatic and urinary
catecholamines (Goldstein et al., 1983), which is nowadays not
considered as a highly reliable index of sympathetic activity
(Esler, 1993; Montano et al., 2009), (b) muscle sympathetic
nerve activity (MSNA), a direct but invasive recording of sympa-
thetic activity using a microneurography technique (Wallin and
Charkoudian, 2007), (c) analysis of HRV, a non-invasive tool able
to provide reliable information on sympathetic and parasympa-
thetic oscillations of the heart period and arterial pressure time
series, (d) more recent non-linear approaches based on entropy-
derived measures and symbolic analysis of heart period time
series (Porta et al., 2007a,b; Tobaldini et al., 2009).
LINEAR ANALYSIS OF HRV
A pioneering study by Lee and Hon first described significant
changes in beat-to-beat intervals during fetal distress before evi-
dent changes in heart rate (HR) (Lee and Hon, 1965). During the
next years, several evidences supported the hypothesis that rhyth-
mical oscillations of both HR and blood pressure (BP) are indi-
rect measures of sympathetic and parasympathetic modulation
(Pagani et al., 1986; Malliani and Montano, 2002).
Therefore, HRV has been considered a non-invasive and reli-
able tool able to provide information on the sympathetic and
parasympathetic modulation both in physiological and patho-
logical conditions (Malliani et al., 1998; Montano et al., 2009).
It is worth noting that HRV has been widely accepted not only
as a tool to assess physiological autonomic functions, but also
as a method able to provide important clinical information.
Pioneering studies showed that, in post-myocardial infarction
patients, total HRV was an independent predictor of mortality
(Kleiger, 1987; Malik, 1989; Fei et al., 1996).
As stated above, HRV is based on the assessment of rhyth-
mical oscillations embedded in heart period and blood pressure
time series, which represent the sympathetic and parasympa-
thetic modulations of cardiovascular function. Several computa-
tional methods have been validated, classically divided into non
parametric (based on a simple algorithm, usually a fast Fourier
transform) and parametric tools, such as autoregressive algo-
rithm, in which spectral components are identified independently
of preselected frequencies (Task Force of the European Society
of Cardiology and The North American Society of Pacing and
Electrophysiology, 1996).
On the heart period and blood pressure time series, three
main components can be recognized: a very low frequency com-
ponent (VLF), frequency band below 0.04Hz; a low frequency
component (LF), bounded between 0.04–0.15Hz, and a high
frequency component (HF, bounded between 0.15 and 0.4Hz),
synchronous with respiration. The VLF component is considered
to be a marker of humoral and hormonal fluctuations; the LF
component is discussed to represent a marker of both sympa-
thetic and parasympathetic modulation while the HF component
is considered a marker of vagal modulation.
In addition to the frequency band, each oscillation can be
described in terms of amplitude, which can be expressed both
in absolute (ms2 or mmHg2 for heart period and blood pressure
time series, respectively) and in normalized units (nu). LFnu and
HFnu represent the relative value of LF or HF with respect to the
total variability, minus the VLF component (Malliani et al., 1991,
1998; Montano et al., 2009; Malliani and Montano, 2002).
It is worth noting that while HF oscillation is commonly
accepted as a marker of parasympathetic modulation, the phys-
iological meaning of the LF band is still debated. In fact, some
authors have suggested that LF can be the result of sympathetic
and parasympathetic modulation (Berntson et al., 1997; Eckberg,
1997; Billman, 2011, 2013), while, on the contrary, other exper-
imental and clinical data support the hypothesis that LF is a
marker of sympathetic modulation (Malliani et al., 1991, 1998;
Montano et al., 2009).
NON-LINEAR ANALYSIS OF HRV
Classic power spectral analysis of HRV is based on the assumption
that heart period time series contain only linear and station-
ary dynamics; however, in the last years, increasing interest has
been paid to non-linear dynamics that characterize autonomic
cardiovascular control (Goldberger et al., 1988; Kaplan et al.,
1991; Voss et al., 1995). Interestingly, it has been demonstrated
that some non-linear parameters are better predictors of mor-
bidity and mortality than standard linear spectral parameters in
cardiac patients (Mäkikallio et al., 2001). Although several non-
linear methods have been developed, in the present review we
will briefly present entropy-derived measures, which have been
recently applied for the assessment of autonomic cardiovascular
complexity in physiological and pathological sleep.
Entropy-derived measures
Physiologically, biological variables are controlled by the interac-
tion of several systems, which actively interact with each other as
agonists or antagonists at different time scales. In this perspective,
beat-to-beat regulation is under the influence of sympatho-vagal
balance, central oscillators, reflexes circuits such as baroreflex and
chemoreflex control, sympatho-sympathetic reflexes, molecular,
and hormonal regulation. All these mechanisms are responsible
for HRV complexity (Goldberger et al., 1988; Kaplan et al., 1991).
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During aging and pathological situations, one of these mecha-
nisms may become predominant, with a decrease or an inhibition
of the others, thus leading to a decrease of complexity of HRV
and to a simplification of cardiovascular regulation. If this is
the case, plasticity of cardiovascular control is strongly impaired
and the ability of the system to respond to internal and exter-
nal stressor stimuli is significantly damaged. Interestingly, some
complexity indices are powerful predictors of mortality in high-
risk patients (Voss et al., 1996; Huikuri et al., 2003; Clariá et al.,
2008). Complexity is measured by evaluating the amount of infor-
mation carried by a biological series, based on entropy-derived
non-linear indices: the larger is the information, the greater is the
complexity (Porta et al., 2001).
Entropy-derived indices, such as approximate entropy, sam-
ple entropy, corrected conditional entropy (CCE) and Shannon
entropy (SE) have been proposed (Porta et al., 2001). Although
a detailed description of the mathematical basis of these mea-
sures is beyond the scope of this review, we will briefly describe
the key aspects of SE, Conditional Entropy (CE), and CCE, which
have been applied to provide information on cardiac complexity
in normal and pathological sleep.
Shannon entropy (SE)
SE evaluates the complexity of patterns distribution of length L,
RRL = {RRL(i)= (RR(i), RR(i− 1), . . . , RR(i-L+ 1)), i= 1, . . . ,
N-L+ 1)}, by describing the shape of this distribution [SE(L)
describes the shape of the distribution of RRL]. When SE(L) is
calculated with L = 1, it depends on the shape of the distribution
of the heart period time series. When SE(L) is large, the pattern
distribution is flat, meaning that all the patterns are equally dis-
tributed and the amount of information carried by the series is
highest. On the opposite, when SE(L) is small, the pattern dis-
tribution is not flat but characterized by specific shapes (i.e.,
Gaussian or skewed distribution), suggesting that some patterns
are more present while others are less present or absent (Porta
et al., 2001).
Conditional entropy (CE) and corrected conditional entropy (CCE)
CE measures the quantity of information carried by the cur-
rent RR sample when the previous samples are known. In other
words, CE corresponds to the difficulty in predicting future val-
ues of RR intervals based on past values of the same series. CE
is 0 when future values of RR are completely predictable given
RR past values and it is equal to SE(1) when the knowledge of
past values of RR is not helpful to reduce the uncertainty of
future RR values. However, because the estimation of CE is biased
(CE became unreliable as a function of L, decreasing very fast
toward 0 with L independently of the ability of past values of
RR to predict future RR samples), CCE was designed to over-
come this mathematical limitation. CCE decreased to 0 when
new sample is completely predictable, remained to the maximum
value [i.e., SE(1)] when the new sample is fully unpredictable
and showed a minimum when the knowledge of past values
was helpful to reduce the uncertainty associated to future values
(Porta et al., 2007a).
From CCE, it is possible to derive an index of regularity, Ro
(obtained by dividing CCE by the Shannon entropy), which is
bounded between 1 (maximum regularity, lowest complexity) to
0 (lowest regularity, maximum complexity).
HEART RATE VARIABILITY IN WAKE/SLEEP STATES
The interaction between ANS and sleep is complex, bidirectional
and regulated by several different factors. In fact, changes in ANS
regulation can profoundly affect sleep onset and sleep home-
ostasis and, on the opposite, modifications of physiological sleep
can impinge upon autonomic cardiovascular regulation. It is well
known that sleep is a complex phenomenon in which autonomic
cardiac control fluctuates between sympathetic and parasympa-
thetic predominance, mainly according to the transition to differ-
ent sleep stages (wakefulness, NREM and REM). Somers and col-
leagues showed that the cardiovascular system is strongly affected
by the sleep stage: in fact, from N1 to N3, the stage of highest
neural synchronization, a gradual decrease is observed in HR, BP
and MSNA, with minimum values reached during N3, also called
“quiet sleep” (Somers et al., 1993). REM sleep, however, is charac-
terized by an opposite behavior, with a sort of “activation” of car-
diovascular system to levels sometimes higher than wakefulness.
Thus, the transition fromNREM to REM is accompanied by a sig-
nificant increase of HR, BP, and MSNA, and, more interestingly,
not stable but with continuous fluctuations of the cardiovascu-
lar system, suggesting that cardiovascular control is very complex
and influenced by several factors during this sleep stage.
Interestingly, animal studies showed that during REM sleep,
sympathetic outflows from different sources (i.e., renal and lum-
bar sympathetic outflows) may change independently from each
other, supporting the hypothesis that a differentiate control of
sympathetic outflows could be important for arterial pressure
regulation (Yoshimoto et al., 2011).
So far, several studies investigating the change of autonomic
cardiovascular control by means of HRV during wake and differ-
ent sleep stages provided fundamental information regarding the
relation between autonomic fluctuations and the shift to different
sleep stages (Vanoli et al., 1995; Vaughn et al., 1995; Elsenbruch
et al., 1999; Crasset et al., 2001; Trinder et al., 2001). According
to the changes of HR, BP and MSNA, transition from wake to
NREM sleep is associated with a gradual increase in parasym-
pathetic modulation, expressed by an increased HF component
and a decreased of LF component of HRV (Cajochen et al., 1994;
Busek et al., 2005). Although the meaning of LF oscillation is
someway still debated, the decrease of LF rhythm together with
the changes in MSNA and BRS seem to suggest a global decrease
of sympathetic modulation from wake to NREM sleep.
On the opposite, from NREM to REM sleep a significant
reduction in total HRV together with a shift of sympatho-vagal
balance toward a vagal withdrawal and a possible sympathetic
predominance has been reported (Berlad et al., 1993; Baharav
et al., 1995; Versace et al., 2003).
Beyond these general considerations, it is worth noting that
several factors can influence autonomic control during sleep
stages, such as the stage preceding the change and the sleep
cycle time point. In fact, it has been suggested that the degree
of increased sympathetic modulation during REM sleep depends
on the previous sleep stage, with significantly higher values of
LF/HF ratio during N2 preceding REM sleep compared to N2
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preceding N3, supporting the hypothesis that autonomic control
varies not only according to the sleep stage but also in relation to
the preceding and following stages (Busek et al., 2005).
As to the sleep cycle, it has been reported that REM sleep at
the end of the night is characterized by an increased sympathetic
modulation compared to REM sleep that occurs during the first
part of the night. From a clinical point of view, this fact can be
a potential link between increased sympathetic drive, REM sleep
and the incidence of cardiovascular events in the early morning
(Muller et al., 1995; Scholz et al., 1997; Verrier and Josephson,
2009).
The evaluation of spontaneous baroreflex sensitivity (BRS)
revealed important information on the cardiac and vascular inter-
action through baroreflex circuit during sleep. In fact, it has been
observed that during REM sleep, BRS is higher compared to noc-
turnal wakefulness (Monti et al., 2002). During the first sleep
cycle, BRS is higher during NREM compared to wakefulness and
REM, while, during the last one, BRS is increased during REM
compared to NREM, thus suggesting that the efficacy of barore-
flex control in blunting REM sympathetic drive is higher during
the late sleep cycles (Legramante et al., 2003). Interestingly, this
phenomenon is even more evident in hypertensive patients, in
which the blunted BRS and the increase of sympathetic modu-
lation are greater at the end of the night, possibly implicating the
occurrence of cardiovascular events (Drager et al., 2009).
In addition to classic HRV analysis, the application of non-
linear entropy-derived measures revealed important changes of
autonomic cardiovascular complexity peculiar for each sleep
stage. However, due to the large amount of non-linear methods
and experimental protocol differences, conclusive results are still
lacking.
For instance, previous data showed that NREM sleep is char-
acterized by an increased Sample Entropy while during REM
sleep controversial results have been reported, from an increase of
Approximate Entropy to a decrease of Sample Entropy (Virtanen
et al., 2007; Vigo et al., 2010). A recent study by Viola and col-
leagues showed that CCE and SE were significantly lower during
REM sleep compared to wake and NREM sleep (Viola et al.,
2011), and this reduction was more evident in aged people. These
data suggested the hypothesis that in aged people, REM sleep
more than NREM sleep could be considered a stage of reduced
complexity of cardiovascular control, thus, a stage of potential
increased cardiovascular risk (see Figure 2).
However, it is worth noting that NREM sleep is not a sta-
ble phenomenon; indeed it is punctuated by the occurrence of
arousals, which represent transient episodes of cortical and auto-
nomic activation. Moreover, besides the conventional arousals,
characterized by fast EEG frequencies (within the alpha, 8–12Hz,
and beta, >16Hz range), other EEG phasic patterns, such as
K-complexes and bursts of slow waves are associated with an acti-
vation of vegetative and somatomotor functions (Ferini-Strambi
et al., 2000; Ferri et al., 2000; De Carli et al., 2004; Halász et al.,
2004). Therefore, both fast and slow EEG arousal components
represent a certain degree of cerebral activation reverberating
upon the ongoing autonomic activity (Terzano et al., 1985;
Parrino et al., 2012). During NREM sleep, arousal fluctuations
appear with a pseudo-rhythmic modality, recurring about every
FIGURE 2 | Non-linear analysis of HRV during different sleep stages in
young (black bars) and old (gray bars) subjects during wake (W) and
different sleep stages. Compared to young, the old group have a lower SE.
CCE is significantly reduced in old group compared to young and this
reduction was more evident during REM sleep (from Viola et al., 2011; with
permission). SE, Shannon Entropy; CCE, Corrected Conditional Entropy.
∗p < 0.05, Young vs. Old.
20–40 s. This arousal rhythm, defined under the term of cyclic
alternating pattern (CAP) (Terzano et al., 1985, 1988), represents
a condition of sustained arousal instability.
CAP alternates with phases of stable sleep (non-CAP, NCAP),
characterized by rare and randomly distributed arousal-related
phasic events. Different studies have shown that CAP and NCAP
are accompanied by significant changes of HRV parameters both
in adults and children (Ferini-Strambi and Smirne, 1997; Ferini-
Strambi et al., 2000; Ferri et al., 2000). In particular, during a CAP
phase an increase in LF and LF/HF ratio has been observed, sug-
gesting that during arousal instability the sympatho-vagal balance
is shifted toward a sympathetic predominance (Ferini-Strambi
and Smirne, 1997; Ferri et al., 2000). Moreover, the CAP-related
increase in sympathetic modulation was higher than the mean
value expressed by the corresponding sleep stage as a whole (Ferri
et al., 2000). Interestingly, it has been demonstrated that BRS was
higher during CAP than NCAP sleep, and it was similar during
CAP and REM sleep (Iellamo et al., 2004). The analysis of the rela-
tionships between autonomic functions and CAP/NCAP phases
could represent a more sensitive tool for the investigation of the
effect of sleep disorders on HRV.
HRV AND SLEEP DISORDERS
In the last decades, a growing interest has been focused on
sleep disorders, mainly due to their epidemiological and clinical
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relevance and to their possible association with cardiovascular
diseases. The International Classification of Sleep Disorders clas-
sified sleep disorders into several categories, such as (1) insom-
nias, (2) SDB, (3) hypersomnias, (4) parasomnias, and (5) sleep
related movement disorders.
It is worth noting that most sleep disorders are characterized
by important modifications of physiological sleep, and often by
signs and symptoms of sleep loss, which have been demonstrated
to be independent risk factors for cardiovascular morbidity and
mortality (Wingard et al., 1982; Gallicchio and Kalesan, 2009;
Cappuccio et al., 2010; Redline and Foody, 2011). It has been
suggested that autonomic cardiovascular control could be impor-
tantly implicated as a potential physiopathological link between
sleep disorders and their physiological consequences.
This section will briefly explore HRV changes in three patho-
logical conditions, i.e., SDB, Insomnia, and Sudden Unexpected
Death in Epilepsy, which are characterized by noteworthy alter-
ations of cardiovascular autonomic regulation and increased
cardiovascular risk.
HRV IN SLEEP DISORDERED BREATHING
SDB is a group of diseases characterized by significant alter-
ations of breathing during sleep, which cause fragmentation of
physiological sleep, symptoms of sleep deprivation and altered
gas exchanges during the night. The most common SDB is
Obstructive Sleep Apnea (OSA), which has a prevalence of 2–4%
in middle age population.
OSA is associated with repetitive episodes of apneas during
sleep, with partial or complete collapse of the upper airway during
inspiration; thus, the increased resistance in the upper airways,
caused by the collapse of the pharynx and hypopharynx mus-
cles, lead to paradoxical thoracic and abdominal movements in
order to overcome the airway obstruction. The frequent episodes
of apneas have three main effects: hypoxia and hypercapnia due
to gas exchange alterations, sleep fragmentation with repetitive
arousal and, finally, irritability, daytime sleepiness and altered
cognitive performance.
The clinical relevance of OSA is related to its strong associa-
tion with obesity, hypertension, and increased cardiovascular risk
(Kales et al., 1984; Bliwise et al., 1988; Hung et al., 1990; Somers
et al., 1995; Narkiewicz and Somers, 2001). Although the patho-
physiological factors linking OSA and cardiovascular risk are not
completely understood, several evidences support the hypothesis
that sleep fragmentation and intermittent hypoxia cause a chronic
hyperactivation of the sympathetic nervous system, a key com-
ponent of the progression to cardiovascular disease. In addition,
endothelial dysfunction and activation of inflammatory cascade
have been described in OSA patients, possibly mediated by the
activation of the SNS.
OSAmust be suspected in patients with snoring, obesity, resis-
tant hypertension and in patients with signs and/or symptoms of
sleep loss (fatigue, hypersomnolence, daytime sleepiness, cogni-
tive impairment etc.). The diagnosis of OSA is confirmed in the
presence of apneas (defined as a stop in airflow of at least 10 s) and
hypopneas (reduction of 50% of the flow, with an oxygen desat-
uration of >4% and lasting at least 10 s). The number of apneic
events is calculated as the apnea/hypopnea index (AHI), i.e., the
total amount of apneas and hypopneas per hour of sleep. An AHI
lower than five identifies a normal subjects, an AHI between 5
and 15 identifies mild OSA, an AHI between 15 and 30 a moder-
ate OSA and an AHI greater than 30 a severe OSA (Somers et al.,
1995).
The repetitive episodes of apneas have important hemody-
namic and cardiovascular consequences, which result evident
both during nighttime and daytime. Subjects with OSA usu-
ally have higher resting HR and BP (Vanninen et al., 1996).
The autonomic consequences of OSAmainly involve chemoreflex
and baroreflex regulation, with a global shift of the sympatho-
vagal balance toward a sympathetic predominance and a blunted
parasympathetic control (Narkiewicz et al., 1998), evident either
during wake, and during night. Namely, during apneic events, the
physiological inhibition of sympathetic activity by lung inflation
is lacking, causing a significant sympathetic activation which is
responsible for increased in BP and changes in HR. Sympathetic
activity is highest at the end of an apnea, when hypoxia and
hypercapnia reach their maximum levels; after the upper airways
re-opening, it is possible to observe a large raise in blood pres-
sure, which activates baroreflex control and induces a temporary
withdrawal of sympathetic overactivity (Narkiewicz and Somers,
2001). The analysis of HRV revealed that during daytime, moder-
ate to severe OSA patients were characterized by increased cardiac
sympathetic modulation compared to mild-OSA and controls
(Narkiewicz et al., 1998). Compared to controls, OSA subjects are
characterized by a lower total variability and a possible shift of
the sympatho-vagal balance toward a sympathetic predominance
and a vagal withdrawal, as shown by the increase of LF compo-
nent and LF/HF and the decrease of HF component (Narkiewicz
and Somers, 2003; Smietanowski et al., 2006; Kesek et al., 2009)
either during wakefulness and during nighttime (Shiomi et al.,
1996; Vanninen et al., 1996).
It is important to underline a limitation of HRV applica-
tion to sleep studies in OSA at this point. Indeed, the analysis
of HRV during sleep is limited just by the presence of repeti-
tive apneas, leg movements, or arousals, which artificially modify
HRV analysis, introducing a “rhythmic” biological noise able to
alter autonomic cardiovascular oscillations. This problem was
highlighted by few studies that found that a higher AHI was
associated with a higher vagal modulation during NREM sleep
(da Silva et al., 2009) and, in contrast to the general expecta-
tions, in severe OSA patients, a decreased sympathetic regulation
during REM sleep was observed (Gula et al., 2003). In fact,
severe OSA induced an important modification in breathing pat-
tern, which could have per se been a relevant confounding factor
able to impinge upon HRV rhythmical oscillations. For this rea-
son, cardiovascular autonomic assessment in severe OSA patients
can importantly be affected by non-neural oscillations related
to the continuous episodes of apnea which could thereby alter
HRV analysis (Wang et al., 2008); this factor must be taken into
account when analyzing PSG data and interpreting the results.
To this regard, in a recent paper assessing HRV during sleep in
patients with Brugada syndrome diagnosed with or without SDB,
ECG recordings derived from polysomnographic studies were
analyzed, carefully avoiding periods with apneas/hypopneas and
considering only ECG segments associated with stable and regular
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breathing (Tobaldini et al., 2013). This approach allowed the
observation that Brugada syndrome, a rare but life- threatening
disease characterized by ventricular arrhythmias and sudden car-
diac death, more frequent during nighttime, was associated with
an impaired autonomic cardiovascular control in the presence of
comorbid SDB (Tobaldini et al., 2013).
The gold standard therapy for OSA is the application of
continuous positive airway pressure (CPAP), a device able to
maintain open the upper airways during sleep by inflating a
positive pressure airflow, preventing the repetitive airway col-
lapses as previously mentioned (Patel et al., 2003). CPAP ther-
apy is able to improve cardiovascular outcome (Marin et al.,
2005), with a significant reduction of arterial pressure (Faccenda
et al., 2001), inflammatory markers, insulin resistance (Brooks
et al., 1994), and coagulation factors (Phillips et al., 2012). As
to autonomic effects of CPAP, a pioneer study by Somers and
colleagues showed that CPAP is able to acutely affect ANS,
with a significant decrease of MSNA during wake and sleep
(Narkiewicz et al., 1999). Interestingly, even one night of CPAP
treatment was able to affect HRV with a reduction of sympa-
thetic modulation and an improvement of baroreflex control
(Bonsignore et al., 2006; Kufoy et al., 2012). Longer CPAP treat-
ments revealed positive effects on hemodynamic and metabolic
variables, such as an improvement of arterial stiffness, a reduc-
tion of inflammatory response (Arias et al., 2008; Dorkova et al.,
2008) and a decrease of platelet aggregation (Shimizu et al.,
2002). However, the effects of longer CPAP treatments showed
contrasting results and conclusive results on its consequences
on HRV are still lacking. For instance, a reduction of the LF
component and the LF/HF ratio, have been described, likely
to be related to an improvement of chemoreflex and barore-
flex responses (Roche et al., 1999; Khoo et al., 2001). Very
recently, it has been described that long term CPAP (2 years treat-
ment) is able to improve the coupling between parasympathetic
modulation and delta wave sleep (Jurysta et al., 2013), suggest-
ing a positive effect of this therapy on central and peripheral
oscillations.
HRV IN INSOMNIA
Insomnia is a sleep disorder characterized by an important inabil-
ity to fall asleep, to stay asleep or to wake up too early, caus-
ing daytime sleepiness, fatigue, mood alterations, and memory
impairment. Insomnia is one of themost common sleep disorders
and it can be classified into (1) comorbid insomnia, i.e., associ-
ated with other diseases, either physical and mental, (2) primary
insomnia (PI), i.e., unrelated to any other disease, and (3) chronic
(or long-standing) insomnia.
Apart from the relevant effects on day-life activity, the impor-
tance of insomnia as a potential modifiable risk factor for the
development of cardiovascular diseases has been recently under-
lined (Spiegelhalder et al., 2010; Redline and Foody, 2011).
The assessment of ANS control in insomniac patients revealed
interesting results. A pioneer study by Bonnet and colleagues
showed a significant increase of the LF component and a decrease
of the HF component of HRV in insomniacs compared to healthy
subjects during sleep; these data suggested for the first time
that insomnia is characterized by a predominant sympathetic
modulation not only during wake but also across sleep stages
(Bonnet and Arand, 1998).
These results have been confirmed by successive studies, which
showed that PI patients exhibit a constant sympathetic over-
activity during night (de Zambotti et al., 2013) and a marked
reduction of vagal modulation, indicated by the decrease of the
HF component of HRV during the night (Spiegelhalder et al.,
2011; Yang et al., 2011).
These data support the hypothesis that in PI patients,
sympatho-vagal balance is shifted toward a sympathetic predom-
inance. Furthermore, the analysis of complexity indexes using
entropy derived measures showed a considerable decrease in
complexity during nighttime compared to healthy subjects, thus
suggesting a possible link with cardiovascular diseases (Yang et al.,
2011).
It is worth noting that PI patients do not only have an impaired
autonomic cardiac modulation, but also an altered coupling
between HRV and delta sleep. In fact, analyzing the relationship
between the HF component and EEG delta power, PI patients
showed a decreased HF-delta EEG coherence with respect to
controls, thus suggesting a significant change in the interaction
between central and peripheral drives (Jurysta et al., 2009).
In summary, insomnia is a very common sleep disorder, rele-
vant for its prevalence over general population and for its clinical
consequences. An altered autonomic cardiovascular control has
been described in insomniac patients, who show a shift of the
sympatho-vagal balance toward a predominance of sympathetic
modulation both during wake and night; this alteration could be
responsible for increased risk of cardiovascular diseases.
HRV, SLEEP, AND SUDDEN UNEXPECTED DEATH IN EPILEPSY (SUDEP)
Epilepsy is a brain disorder characterized by an enduring pre-
disposition to generate seizures. Seizures are paroxysmal tran-
sient disturbances of brain functions that may be manifested as
episodic impairment or loss of consciousness, abnormal motor
phenomena and psychic or sensory disturbances. Moreover,
seizures can induce a perturbation of the ANS; indeed, neuroveg-
etative symptoms such as cardiovascular and respiratory changes,
gastro-intestinal, cutaneous, and genito-urinary manifestations,
frequently occur during epileptic seizures (Baumgartner et al.,
2001; Leutmezer et al., 2003). Finally, it has been shown that
also sub-clinical epileptic discharges may be associated with auto-
nomic instability (Brotherstone and McLellan, 2012).
In epileptic patients, especially in those with pharmacoresis-
tant epilepsy, the risk of sudden unexpected death (SUDEP) is
24–40 times higher with respect to the general population (Ficker
et al., 1998; Mohanraj et al., 2006). SUDEP is considered to be the
result of a peri-ictal concurrence of a number of predisposing and
precipitating factors (Nobili et al., 2011); nevertheless SUDEP is
primarily a sleep related phenomenon and sleep related seizures
seem to be an independent risk factor for SUDEP (Lamberts et al.,
2012). Previous studies have shown decreased HRV in chronic
epileptic patients suggesting that this might play a role in the
pathophysiology of SUDEP (Tomson et al., 1998; Ansakorpi et al.,
2000; Ronkainen et al., 2005). There are many reports suggest-
ing that the autonomic changes observed in epileptic patients
are mainly evident during nocturnal sleep. Indeed, patients (both
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adult and children) with focal epilepsy exhibit a higher reduction
of HRV during night-time with respect to control subjects, indi-
cating that the sleep period in epileptic patients might be more at
risk of developing alterations of autonomic heart control (Ferri
et al., 2002; Ronkainen et al., 2005; Persson et al., 2007). In a
recent study, conducted in a population of drug resistant epileptic
children with different clinical syndromes, authors found a strik-
ing reduction in vagal modulation during slow-wave sleep and a
small autonomic modulation capacity (Jansen et al., 2011).
There is no definitive interpretation whether the observed
autonomic changes in epileptic patients are due to the recur-
rence of seizures, the interictal epileptic discharges, and/or to
the drug treatment. Seizures and periodic epileptic discharges,
increasing arousal fluctuations during NREM sleep, might lead
to a chronic stimulation of the ANS which are reflected by
changes in HRV parameters. The relevant role of seizures and
epileptic discharges on HRV change seems to be confirmed by
the observation that, in drug resistant patients, HRV improves
after epilepsy surgery especially in those with a positive out-
come (Hilz et al., 2002; Dütsch et al., 2004; Persson et al., 2005).
Also antiepileptic drugs could influence the autonomic state;
in particular carbamazepine and polytherapy seem to reduce
HRV (Persson et al., 2003; Yildiz et al., 2011). A recent sys-
tematic review of case-control studies, enrolling patients with
different epilepsy syndromes and from infancy to adulthood, con-
firmed that epileptic patients present lower HF values, indicating
impaired vagal control associated with increased cardiovascular
risk and arrhythmias (Lotufo et al., 2012). Moreover a trend
for lower LF ratios was identified in epileptic patients using
pharmacotherapy.
In conclusion, the reduction of HRV that has been found
in patients with epilepsy seems to be more pronounced during
the night, thus affecting the circadian HRV. Further studies are
needed to assess the possible association between altered HRV
and risk of sudden death during sleep in epileptic patients.
CONCLUSIONS
In summary, sleep is a complex biological phenomenon regulated
by different biological pathways. Cardiovascular autonomic con-
trol plays a key role, varying among the transition to different
sleep stages. In addition, the sleep-autonomic link has to be con-
sidered bidirectional: in fact, autonomic changes can importantly
alter sleep regulation and, on the other side, sleep disturbances
can profoundly alter the physiological cardiac autonomic mod-
ulation. Nowadays, an increasing prevalence of sleep disorders
such as SDB and neurological sleep related disturbances have
been described. The assessment of autonomic cardiovascular con-
trol using classical linear and more recent non-linear analysis
of HRV have been widely used as non-invasive tools to provide
important information on autonomic changes in physiological
and pathological sleep.
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